Dr. Mateos has wide-ranging research interests including the biology of plasma cells and new drug development and has organized numerous clinical trials in elderly patients and patients with smoldering myeloma. She is an advocate for early treatment of MM, especially subsets of smoldering MM patients that appear to benefit from early intervention, and as a consequence, her work has influenced treatment options within Spain and beyond.